Personal information

Germany

Activities

Employment (1)

University of Duisburg-Essen: Essen, Nordrhein-Westfalen, DE

2020-03-01 to present (Department of Infectious Diseases, West German Centre of Infectious Diseases)
Employment
Source: Self-asserted source
Lukas van de Sand

Works (15)

Sequential Vaccination Against Streptococcus pneumoniae Appears as Immunologically Safe in Clinically Stable Kidney Transplant Recipients

Vaccines
2024-10-31 | Journal article
Contributors: Monika Lindemann; Lukas van de Sand; Nils Mülling; Kim L. Völk; Ulrich W. Aufderhorst; Benjamin Wilde; Peter A. Horn; Andreas Kribben; Adalbert Krawczyk; Oliver Witzke et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Antibody responses after sequential vaccination with PCV13 and PPSV23 in patients with moderate to severe plaque psoriasis under immunosuppressive therapy

mBio
2024-07-17 | Journal article
Contributors: Lorena Helmer; Lukas van de Sand; Thea Wojtakowski; Mona Otte; Oliver Witzke; Wiebke Sondermann; Adalbert Krawczyk; Monika Lindemann; Rino Rappuoli
Source: check_circle
Crossref

Inhibiting the NADase CD38 improves cytomegalovirus-specific CD8+ T cell functionality and metabolism.

The Journal of clinical investigation
2024-07-02 | Journal article
Contributors: Mülling N; Behr FM; Heieis GA; Boss K; van Duikeren S; van Haften FJ; Pardieck IN; van der Gracht ET; Vleeshouwers W; van der Sluis TC et al.
Source: Self-asserted source
Lukas van de Sand

Immune responses in COVID-19 patients during breakthrough infection with SARS-CoV-2 variants Delta, Omicron-BA.1 and Omicron-BA.5.

Frontiers in immunology
2023-07-13 | Journal article
Contributors: Bormann M; Brochhagen L; Alt M; Otte M; Thümmler L; van de Sand L; Kraiselburd I; Thomas A; Gosch J; Braß P et al.
Source: Self-asserted source
Lukas van de Sand

Antibody responses after sequential vaccination with PCV13 and PPSV23 in kidney transplant recipients

Infection
2023-05-27 | Journal article
Part of ISSN: 0300-8126
Part of ISSN: 1439-0973
Contributors: Nils Mülling; Lukas van de Sand; Kim Völk; Ulrich Wilhelm Aufderhorst; Mark van der Linden; Peter A. Horn; Andreas Kribben; Benjamin Wilde; Adalbert Krawczyk; Oliver Witzke et al.
Source: Self-asserted source
Lukas van de Sand

Cell-to-cell spread inhibiting antibodies constitute a correlate of protection against herpes simplex virus type 1 reactivations: A retrospective study

Frontiers in Immunology
2023-03-16 | Journal article
Part of ISSN: 1664-3224
Contributors: Mira Alt; Susanne Wolf; Lukas van de Sand; Robin Dittrich; Tobias Tertel; Leonie Brochhagen; Miriam Dirks; Ulrich Wilhelm Aufderhorst; Laura Thümmler; Mona Otte et al.
Source: Self-asserted source
Lukas van de Sand

Upregulation of miRNA-200c during Disease Progression in COVID-19 Patients

Journal of Clinical Medicine
2022-12 | Journal article | Author
Contributors: Lukas van de Sand; Peer Braß; Jonas Gregorius; Kevin Thomas Pattberg; Andrea Engler; Ulf Dittmer; Christian Taube; Stephan Brock; Marc Moritz Berger; Thorsten Brenner et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Decline of Humoral Responses 6 Months after Vaccination with BNT162b2 (Pfizer–BioNTech) in Patients on Hemodialysis

Vaccines
2022-02-18 | Journal article
Contributors: Michael Jahn; Johannes Korth; Oliver Dorsch; Olympia Evdoxia Anastasiou; Adalbert Krawczyk; Leonie Brochhagen; Lukas van de Sand; Burkhard Sorge-Hädicke; Bartosz Tyczynski; Oliver Witzke et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Turmeric Root and Its Bioactive Ingredient Curcumin Effectively Neutralize SARS-CoV-2 In Vitro

Viruses
2021-09 | Journal article | Author
Contributors: 0000-0002-0955-1453; Mira Alt; Leonie Schipper; Lukas van de Sand; Vu Thuy Khanh Le-Trilling; Lydia Rink; Natalie Heinen; Rabea Julia Madel; Mona Otte; Korbinian Wuensch et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Antiviral Active Compounds Derived from Natural Sources against Herpes Simplex Viruses

Viruses
2021-07-16 | Journal article
Contributors: Lukas van de Sand; Maren Bormann; Yasmin Schmitz; Christiane Silke Heilingloh; Oliver Witzke; Adalbert Krawczyk
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Recent Antiviral Treatment and Vaccination Strategies Against SARS-CoV-2

Klinische Monatsblätter für Augenheilkunde
2021-05 | Journal article
Contributors: Maren Bormann; Lukas van de Sand; Oliver Witzke; Adalbert Krawczyk
Source: check_circle
Crossref

Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease

Viruses
2021-04 | Journal article | Author
Contributors: Lukas van de Sand; 0000-0002-0955-1453; Mira Alt; Leonie Schipper; Christiane Silke Heilingloh; Eike Steinmann; Daniel Todt; Ulf Dittmer; Carina Elsner; Oliver Witzke et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Disinfection of SARS-CoV-2 Contaminated Surfaces of Personal Items with UVC-LED Disinfection Boxes

Viruses
2021-03 | Journal article | Author
Contributors: 0000-0002-0955-1453; Mira Alt; Leonie Schipper; Lukas van de Sand; Mona Otte; Toni Luise Meister; Ulf Dittmer; Oliver Witzke; Eike Steinmann; Adalbert Krawczyk
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 3)‎

SARS-CoV-2-specific humoral and cellular immunity in two renal transplants and two hemodialysis patients treated with convalescent plasma.

Journal of medical virology
2021-02-02 | Journal article
Source: Self-asserted source
Lukas van de Sand

Glycyrrhizin effectively neutralizes SARS-CoV-2 in vitro by inhibiting the viral main protease

[]
2020-12-20 | Preprint
Source: Self-asserted source
Lukas van de Sand